There are four members of the myocyte enhancer binding factor 2 (MEF2) family of transcription factors, MEF2A, -B, -C, and -D, that have homology within an amino-terminal MADS box and an adjacent MEF2 domain that together mediate dimerization and DNA binding. MEF2A, -C, and -D have previously been shown to bind an A/T-rich DNA sequence in the control regions of numerous muscle-specific genes, whereas MEF2B was reported to be unable to bind this sequence unless the carboxyl terminus was deleted. To further define the functions of MEF2B, we analyzed its DNA binding and transcriptional activities. In contrast to previous studies, our results show that MEF2B binds the same DNA sequence as other members of the MEF2 family and acts as a strong transactivator through that sequence. Transcriptional activation by MEF2B is dependent on the carboxyl terminus, which contains two conserved sequence motifs found in all vertebrate MEF2 factors. During mouse embryogenesis, MEF2B transcripts are expressed in the developing cardiac and skeletal muscle lineages in a temporospatial pattern distinct from but overlapping with those of the other Mef2 genes. The mouse Mef2b gene maps to chromosome 8 and is unlinked to other Mef2 genes; its intron-exon organization is similar to that of the other vertebrate Mef2 genes and the single Drosophila Mef2 gene, consistent with the notion that these different Mef2 genes evolved from a common ancestral gene.The myocyte enhancer binding factor 2 (MEF2) family comprises a group of transcription factors that have homology within a MADS (MCM1-agamous-deficients-serum response factor) box at their amino termini and an adjacent motif known as the MEF2 domain (reviewed in reference 39). There are four Mef2 genes in vertebrates, Mef2a-d, whose products bind as homo-and heterodimers to the A/T-rich DNA sequence CTA(A/T) 4 TAG/A (2, 3, 5, 20, 29-31, 41, 50). MEF2 binding sites were first identified in the control regions of musclespecific genes, where they are required for transcriptional activation (8). More recently, they have also been shown to be important for serum inducibility of the c-jun gene (10, 11). There is a single Mef2 gene, D-mef2, in Drosophila melanogaster, which encodes a protein with the same DNA binding properties as the vertebrate MEF2 factors (21, 37). This gene has been shown to be required for differentiation of skeletal, cardiac, and visceral muscle cells in the Drosophila embryo (1, 22, 42).The MADS and MEF2 domains mediate DNA binding and dimerization of MEF2 monomers (33, 41). MEF2 factors can also interact with heterodimers formed between myogenic basic helix-loop-helix (bHLH) factors, such as MyoD and myogenin, and ubiquitous bHLH proteins (32). Amino acids in the MADS and MEF2 domains appear to be the primary determinants of this type of protein-protein interaction (32). MEF2A, -C, and -D show similar DNA binding and transcriptional activation properties (2, 29-31, 41, 50). In contrast, it has been reported that human MEF2B is unable to bind the MEF2 consensus sequence unles...